The Ministry of Food and Drug Safety ordered recalls after impurities, label errors, and packaging problems were found in some medicines made by pharmaceutical companies including Daewon ...

Over 140,000 bottles of a prescription statin have been recalled due to "failed dissolution specifications," according to a U.S. Food and Drug Administration (FDA) enforcement report. Ascend ...

More than 140,000 bottles of a widely prescribed cholesterol medication have been pulled from the market after failing to meet quality standards. Ascend Laboratories of New Jersey issued the recall ...

This 24-week, randomized, open-label trial (Trial Number: 4522IL/0029) was conducted at 39 participating centers in the United States. [21] Eligible patients were randomized at a 2:3:3:3 ratio to ...

Background: Guidelines for dyslipidemia management recommend adding ezetimibe for patients with dyslipidemia inadequately controlled with statin monotherapy. A fixed-dose combination (FDC) of statin ...

Sun Pharmaceutical Industries has announced the launch of FEXUCLUE, a novel potassium-competitive acid blocker (P-CAB), in India. The drug, available in 40 mg tablets, is approved as a new treatment ...

Sun Pharmaceutical Industries Limited has announced the launch of FEXUCLUE® (Fexuprazan) 40 mg tablets in India, a novel treatment for Erosive Esophagitis. FEXUCLUE® is a Potassium-Competitive Acid ...

Department of Clinical Research, Industrias Biocontrolled C.A., Caracas, Venezuela. This study was conducted ethically in accordance with the principles of the Declaration of Helsinki (Brazil, 2.013) ...